Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments ...

Originally a small company producing medical products like first aid kits and dental floss, Johnson & Johnson evolved into a global healthcare powerhouse valued at $384.03 billion today.

The verdict, delivered on Tuesday, marks another chapter in the ongoing litigation over the safety of J&J's talcum powder ...

In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against other worst performing Dow stocks year-to-date. After the disastrous performance of 2022 ...

Oral hygiene encompasses a variety of products aimed at maintaining oral health, such as toothpaste, toothbrushes, mouthwash, ...

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and ...

Packing for vacations can be difficult, especially if you're new to traveling. We've all been there at some point, but once ...

It was originally formed in 1866 when three brothers (Robert, Edward, and James Johnson) founded the company to focus on producing bandages and baby products. It has since grown into one of the ...

On Tuesday, Johnson & Johnson (NYSE:JNJ) reported a third-quarter adjusted EPS of $2.42, down 9.0% year-over-year, beating the consensus of $2.21. The pharmaceutical giant reported sales of $22.47 ...

MedTech sales growth was led by electrophysiology and cardiovascular products. Johnson & Johnson’s adjusted net earnings margin stood at 26.1% during the quarter, compared to 31.7% in the prior ...

Johnson & Johnson shares initially rose Tuesday after the drugmaker reported better-than-expected third-quarter sales and raised full-year revenue guidance. However, the stock pulled back and was ...